NCT04392063View on ClinicalTrials.gov

Melatonin for Cerebral Palsy Children's Sleep and Health

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

September 30, 2018

Conditions
Cerebral PalsyMelatoninGrowthChildren, Only
Interventions
DRUG

Melatonin 3 mg

The children received crushed Melatonin 3-mg tablets daily, 30-minutes before bedtime for 3-months.

Trial Locations (1)

11381

Children's Hospital, Faculty of Medicine, Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04392063 - Melatonin for Cerebral Palsy Children's Sleep and Health | Biotech Hunter | Biotech Hunter